{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:29:50Z","timestamp":1793496590330,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jogc.2024.102694","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:16:25Z","timestamp":1729073785000},"page":"102694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Guideline No. 456: Prenatal Screening for Fetal Chromosomal Anomalies"],"prefix":"10.1016","volume":"46","author":[{"given":"Francois","family":"Audibert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"De Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Douglas","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2024.102694_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jogc.2017.01.032","article-title":"No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes","volume":"39","author":"Audibert","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-90-481-9485-8_20","article-title":"The prevalence of congenital anomalies in Europe","volume":"686","author":"Dolk","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jogc.2024.102694_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/pd.6395","article-title":"The First Trimester: The new focal point for prenatal screening and diagnosis","author":"Hui","year":"2023","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jogc.2021.05.004","article-title":"Committee Opinion No. 418: The Complete 11-14 Week Prenatal Sonographic Examination","volume":"43","author":"Simula","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jogc.2018.09.020","article-title":"No. 375-Clinical Practice Guideline on the Use of First Trimester Ultrasound","volume":"41","author":"Van den Hof","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jogc.2017.06.031","article-title":"No. 352-Technical Update: The Role of Early Comprehensive Fetal Anatomy Ultrasound Examination","volume":"39","author":"Nevo","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.20352","article-title":"Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency","volume":"55","author":"Sinajon","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib8","first-page":"E1","article-title":"AIUM Practice Parameter for the Performance of Detailed Diagnostic Obstetric Ultrasound Examinations Between 12 Weeks 0 Days and 13 Weeks 6 Days","volume":"40","year":"2021","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.jogc.2024.102694_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/uog.26106","article-title":"ISUOG Practice Guidelines (updated): performance of 11-14-week ultrasound scan","volume":"61","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/uog.17483","article-title":"ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice","volume":"49","author":"Salomon","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0034-1395670","article-title":"ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice","volume":"218","author":"Salomon","year":"2014","journal-title":"Z\u00a0Geburtshilfe Neonatol"},{"key":"10.1016\/j.jogc.2024.102694_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/uog.24888","article-title":"ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan","volume":"59","author":"Salomon","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib13","first-page":"363","article-title":"Noninvasive prenatal testing and fetal sonographic screening: roundtable discussion","volume":"34","author":"Yagel","year":"2015","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.jogc.2024.102694_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/pd.6357","article-title":"Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies","author":"Hui","year":"2023","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/pd.6224","article-title":"Timing of diagnosis of fetal structural abnormalities after the introduction of universal cell-free DNA in the absence of first-trimester anatomical screening","volume":"42","author":"Bardi","year":"2022","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib16","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2023.05.031","article-title":"The value of detailed first-trimester ultrasound in the era of noninvasive prenatal testing","volume":"229","author":"Esteves","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1701-2163(15)30664-2","article-title":"Determination of gestational age by ultrasound","volume":"36","author":"Butt","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib18","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/j.jogc.2017.04.022","article-title":"No. 223-Content of a Complete Routine Second Trimester Obstetrical Ultrasound Examination and Report","volume":"39","author":"Cargill","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1701-2163(16)34961-1","article-title":"Prenatal screening for fetal aneuploidy in singleton pregnancies","volume":"33","author":"Chitayat","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/AOG.0000000000004107","article-title":"ACOG Practice Bulletin Summary, Number 226","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib21","article-title":"First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening","volume":"3","author":"Alldred","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2024.102694_bib22","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jogc.2019.11.069","article-title":"Committee Opinion No. 406: Prenatal Testing After IVF With Preimplantation Genetic Testing for Aneuploidy","volume":"42","author":"Zwingerman","year":"2020","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.20353","article-title":"Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis","volume":"54","author":"Salomon","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib24","article-title":"Amniocentesis and chorionic villus sampling for prenatal diagnosis","volume":"9","author":"Alfirevic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2024.102694_bib25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMcibr2209405","article-title":"Circulating Cell-free DNA and Screening for Trisomies","volume":"387","author":"Norton","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102694_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.07.002","article-title":"Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies","author":"Rose","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2024.102694_bib27","doi-asserted-by":"crossref","first-page":"E1156","DOI":"10.1503\/cmaj.202456","article-title":"Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada","volume":"193","author":"Dougan","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.jogc.2024.102694_bib28","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100874","article-title":"Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Dungan","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2024.102694_bib30","article-title":"Invasive Prenatal Diagnostic Testing for Aneuploidies in Singleton Pregnancies: A Comparative Review of Major Guidelines","volume":"58","author":"Giovannopoulou","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jogc.2024.102694_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajog.2015.09.077","article-title":"Electronic address eso. SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening","volume":"213","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40246-019-0244-0","article-title":"Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening","volume":"13","author":"Hou","year":"2019","journal-title":"Hum Genomics"},{"key":"10.1016\/j.jogc.2024.102694_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088484","article-title":"Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies","volume":"9","author":"Hudecova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102694_bib34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies","volume":"33","author":"Canick","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib36","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.ajog.2021.04.212","article-title":"Obesity and no call results: optimal timing of cell-free DNA testing and redraw","volume":"225","author":"Hopkins","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib37","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib38","doi-asserted-by":"crossref","first-page":"300.e1","DOI":"10.1016\/j.ajog.2023.03.026","article-title":"Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results","volume":"229","author":"Norton","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib39","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"640: Cell-Free DNA Screening For Fetal Aneuploidy","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib40","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ajhg.2022.04.018","article-title":"Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study","volume":"109","author":"van Prooyen Schuurman","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jogc.2024.102694_bib41","article-title":"Maternal Copy Number Imbalances in Non-Invasive Prenatal Testing: Do They Matter?","volume":"12","author":"Hyblova","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jogc.2024.102694_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2024.102694_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/522029a","article-title":"Pregnancy: Prepare for unexpected prenatal test results","volume":"522","author":"Bianchi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jogc.2024.102694_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/genes13112027","article-title":"Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing Twin","volume":"13","author":"Kleinfinger","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jogc.2024.102694_bib45","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pd.4659","article-title":"The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/GCO.0000000000000610","article-title":"Predicting fetoplacental mosaicism during cfDNA-based NIPT","volume":"32","author":"Neofytou","year":"2020","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/pd.4656","article-title":"Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis","volume":"35","author":"Malvestiti","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/uog.23648","article-title":"Cell-free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10-14 weeks and meta-analysis","volume":"58","author":"Judah","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/aogs.13842","article-title":"Clinical performance of non-invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta-analysis","volume":"99","author":"He","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2024.102694_bib50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/AOG.0000000000004385","article-title":"Performance and Diagnostic Value of Genome-Wide Noninvasive Prenatal Testing in Multiple Gestations","volume":"137","author":"van Riel","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220979","article-title":"A\u00a0new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory","volume":"14","author":"Dyr","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102694_bib52","doi-asserted-by":"crossref","first-page":"332.e1","DOI":"10.1016\/j.ajog.2014.11.041","article-title":"Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes","volume":"212","author":"Wapner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib53","article-title":"Validity and Utility of Non-Invasive Prenatal Testing for Copy Number Variations and Microdeletions: A Systematic Review","volume":"11","author":"Zaninovic","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jogc.2024.102694_bib54","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102694_bib55","article-title":"Ethical issues associated with prenatal screening using non-invasive prenatal testing for sex chromosome aneuploidy","author":"Johnston","year":"2022","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semperi.2018.07.004","article-title":"Introducing new and emerging genetic tests into prenatal care","volume":"42","author":"Vora","year":"2018","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jogc.2024.102694_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253866","article-title":"Have maternal or paternal ages any impact on the prenatal incidence of genomic copy number variants associated with fetal structural anomalies?","volume":"16","author":"Larroya","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102694_bib58","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2022.01.002","article-title":"Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome","volume":"227","author":"Dar","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1756-0500-5-476","article-title":"Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis","volume":"5","author":"Wright","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jogc.2024.102694_bib60","article-title":"The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis","volume":"MFM","author":"Bussolaro","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jogc.2017.05.015","article-title":"Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis","volume":"40","author":"Nshimyumukiza","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102694_bib62","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pd.4311","article-title":"The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada","volume":"34","author":"Okun","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093559","article-title":"Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell\u00a0free fetal DNA in the UK National Health Service","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2024.102694_bib64","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2021.06.079","volume":"225","author":"Prabhu","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/uog.12364","article-title":"Meta-analysis of second-trimester markers for trisomy 21","volume":"41","author":"Agathokleous","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib66","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/AOG.0b013e3181c15064","article-title":"Role of second-trimester genetic sonography after Down syndrome screening","volume":"114","author":"Aagaard-Tillery","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102694_bib67","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/pd.6402","article-title":"Comprehensive prenatal diagnostics: Exome versus genome sequencing","volume":"43","author":"Miceikaite","year":"2023","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib68","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/pd.6157","article-title":"International Society for Prenatal Diagnosis Updated Position Statement on the use of genome-wide sequencing for prenatal diagnosis","volume":"42","author":"Van den Veyver","year":"2022","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib69","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pd.6152","article-title":"Prenatal exomes and genomes - so much new and so much more to learn","volume":"42","author":"Van den Veyver","year":"2022","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102694_bib70","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands","volume":"105","author":"van der Meij","year":"2019","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324005176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324005176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:17:14Z","timestamp":1733149034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216324005176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1701216324005176"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102694","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline No. 456: Prenatal Screening for Fetal Chromosomal Anomalies","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102694"}}